Multiply resistant Gram-positive bacteria

American Journal of Transplantation

Volumn 4, Issue 10 SUPPL., 2004, Pages 31-36

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; CLINDAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BILE DUCT OBSTRUCTION; BLOOD CULTURE; CHOLEDOCHOJEJUNOSTOMY; CYTOMEGALOVIRUS; HEMODIALYSIS; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OPERATION DURATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; URINALYSIS; VANCOMYCIN RESISTANT ENTEROCOCCUS; MICROBIOLOGY; MULTIDRUG RESISTANCE; PENICILLIN RESISTANCE; POSTOPERATIVE COMPLICATION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSPLANTATION;

DRUG RESISTANCE, MULTIPLE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; METHICILLIN RESISTANCE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TRANSPLANTATION;

EID: 16644400610     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6135.2004.00723.x     Document Type: Review

References (36)

1. Wade JJ, Rolando N, Hayllar K, Philpott-Howard J, Casewell MW, Williams R. Bacterial and fungal infections after liver transplantation. an analysis of 284 patients. Hepatology 1995; 21: 1328-1336.
2. Singh N, Gayowski T, Wagener MM, Marino IR. Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin-Transplant 1997; 11: 275-281.
3. Patel R, Badley AD, Larson-Keller J et al. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation 1996; 61: 1192-1197.
4. Newell KA, Millis JM, Arnow PM et al. Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation. Transplantation 1998; 65: 439-442.
5. Orloff SL, Busch AM, Olyaei AJ et al. Vancomycin-resistant Enterococcus in liver transplant patients. Am J Surg 1999; 177: 418-422.
6. Patel R, Allen SL, Manahan JM et al. Natural history of vancomycin-resistant enterococcal colonization in liver and kidney transplant recipients. Liver Transpl 2001; 7: 27-31.
7. Green M, Barbadora K, Michaels M. Recovery of vancomycin-resistant Gram-positive cocci from pediatric liver transplant recipients. J Clin Microbiol 1991; 29: 2503-2506.
8. Papanicolaou GA, Meyers BR, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23: 760-766.
9. Linden PK, Pasculle AW, Manez R et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis 1996; 22: 663-670.
10. Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106: 26S-37S; discussion 48S-52S.
11. Pfundstein J, Roghmann MC, Schwalbe RS et al. A randomized trial of surgical antimicrobial prophylaxis with and without vancomycin in organ transplant patients. Clin Transplant 1999; 13: 245-252.
12. NCCLS. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. NCCLS Document M7-A4, Approved standard. 4th edn. Wayne, PA: NCCLS 1997.
13. HICPAC. Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Report 1995; 44: 1-13.
14. Ostrowsky BE, Trick WE, Sohn AH et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001; 344: 1427-1433.
15. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000; 343: 1925-1932.
16. Weinstein JW, Roe M, Towns M et al. Resistant enterococci: a prospective study of prevalence, incidence, and factors associated with colonization in a University hospital. Infect Control Hosp Epidemiol 1996; 17: 36-41.
17. Steffen R, Reinhartz O, Blumhardt G et al. Bacterial and fungal colonization and infections using oral selective bowel decontamination in orthotopic liver transplantations. Transpl Int 1994; 7: 101-108.
18. Bonten MJ, Hayden MK, Nathan C et al. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 1996; 348: 1615-1619.
19. Mathis S, Shah N, Friedman GS, Villadolid J, Kalafatas K. Pharmacokinetic interaction of chloramphenicol with calcineurin in hibitors. Am J Transplant 2001; 1 (Suppl. 1): 140.
20. Fridkin SK, Gaynes RP. Antimicrobial resistance in intensive care units. Clin Chest Med 1999; 20: 303-316, viii.
21. Bert F, Galdbart JO, Zarrouk V et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clin Infect Dis 2000; 31: 1295-1299.
22. Singh N, Paterson DL, Chang FY et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant Gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000; 30: 322-327.
23. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus-associated factors and eradication. Infect Control Hosp Epidemiol 1996; 17: 20-28.
24. Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis 2001; 7: 178-182.
25. Wenzel RP, Perl TM. The significance of nasal carriage of Staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995; 31: 13-24.
26. Yu VL, Goetz A, Wagener M et al. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N Engl J Med 1986; 315: 91-96.
27. Kluytmans JA, Mouton JW, VandenBergh MF et al. Reduction of surgical-site infections in cardiothoracic surgery by elimination of nasal carriage of Staphylococcus aureus. Infect Control Hosp Epidemiol 1996; 17: 780-785.
28. Paterson DL, Rihs JD, Squier C, Gayowski T, Sagnimeni A, Singh N. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates. Transplantation 2003; 75: 194-198.
29. Garner JS. Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996; 17: 53-80.
30. Chambers HF. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin Microbiol Rev 1997; 10: 781-791.
31. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
32. Smith TL, Pearson ML, Wilcox KR et al. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N Engl J Med 1999; 340: 493-501.
33. Reverdy ME, Jarraud S, Bobin-Dubreux S et al. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001; 7: 267-272.
34. Fridkin SK. Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know. Clin Infect Dis 2001; 32: 108-115.
35. Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR Morb Mortal Wkly Report 1997; 46 (626-628): 635.
36. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001; 7: 327-332.